• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期心力衰竭患者中性粒细胞胞外陷阱形成——初步报告。

Neutrophil Extracellular Trap Formation in Advanced Heart Failure Patients-Preliminary Report.

机构信息

Cardiac Surgery and Transplantology Department, Poznan University of Medical Sciences, 61-107 Poznan, Poland.

Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, 61-107 Poznan, Poland.

出版信息

Int J Mol Sci. 2024 Sep 5;25(17):9633. doi: 10.3390/ijms25179633.

DOI:10.3390/ijms25179633
PMID:39273580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11487443/
Abstract

In end-stage heart failure, which is characterized by persistent or progressive ventricular dysfunction despite optimal medical therapy, a left ventricular assist device (LVAD) can be beneficial. Congestive heart failure provokes inflammatory and prothrombotic activation. The aim of this study was to evaluate the serum concentration of citrullinated histone 3 (CH3) representing neutrophil extracellular trap (NET) formation in patients referred for LVAD implantation. There were 10 patients with a median age of 61 (57-65) years enrolled in a prospective single-center analysis who underwent LVAD implantation. The CH3 plasma concentration was measured preoperatively and on the 1st and 7th postoperative days, followed by control measurements on the median (Q1-3) 88th (49-143) day. The preoperative CH3 concentration strongly correlated with brain natriuretic peptide (r = 0.879, < 0.001). Significant differences in CH3 serum concentration were observed between pre- and postoperative measurements, including an increase on the first postoperative day ( < 0.001), as well as a decrease on the seventh day ( = 0.016) and in follow-up ( < 0.001). CH3 concentration, as a marker of NET formation, decreases after LVAD implantation.

摘要

在终末期心力衰竭中,尽管采用了最佳的药物治疗,但仍存在持续或进行性心室功能障碍,此时左心室辅助装置(LVAD)可能有益。充血性心力衰竭会引发炎症和促血栓形成的激活。本研究旨在评估因 LVAD 植入而接受评估的患者血清中代表中性粒细胞胞外诱捕网(NET)形成的瓜氨酸化组蛋白 3(CH3)的浓度。前瞻性单中心分析纳入了 10 名中位年龄为 61(57-65)岁的患者,这些患者接受了 LVAD 植入。在术前和术后第 1 天和第 7 天测量 CH3 血浆浓度,然后在第 88 天(49-143)中位数(Q1-3)进行对照测量。术前 CH3 浓度与脑钠肽(BNP)呈强相关(r = 0.879,<0.001)。在术前和术后测量中,CH3 血清浓度存在显著差异,包括术后第 1 天增加(<0.001),第 7 天下降(=0.016)和随访时下降(<0.001)。作为 NET 形成的标志物,CH3 浓度在 LVAD 植入后降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ee2/11487443/4c49d471cd24/ijms-25-09633-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ee2/11487443/126283afeec2/ijms-25-09633-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ee2/11487443/4c49d471cd24/ijms-25-09633-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ee2/11487443/126283afeec2/ijms-25-09633-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ee2/11487443/4c49d471cd24/ijms-25-09633-g002.jpg

相似文献

1
Neutrophil Extracellular Trap Formation in Advanced Heart Failure Patients-Preliminary Report.晚期心力衰竭患者中性粒细胞胞外陷阱形成——初步报告。
Int J Mol Sci. 2024 Sep 5;25(17):9633. doi: 10.3390/ijms25179633.
2
Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device.神经激素调节与血糖控制改善:非搏动性心室辅助装置患者胰岛素需求量的降低
Heart Surg Forum. 2014 Apr;17(2):E98-102. doi: 10.1532/HSF98.2013323.
3
B-Type Natriuretic Peptide Levels Predict Ventricular Arrhythmia Post Left Ventricular Assist Device Implantation.B型利钠肽水平可预测左心室辅助装置植入术后室性心律失常
Artif Organs. 2015 Dec;39(12):1051-5. doi: 10.1111/aor.12486. Epub 2015 Apr 10.
4
Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure.晚期心力衰竭患者在植入心室辅助装置后细胞外基质代谢标志物与右心衰竭的发生。
J Heart Lung Transplant. 2012 Jan;31(1):37-45. doi: 10.1016/j.healun.2011.10.007. Epub 2011 Nov 9.
5
Use of left ventricular assist device (HeartMate II): a Singapore experience.左心室辅助装置(HeartMate II)的应用:新加坡的经验
Artif Organs. 2014 Jul;38(7):543-8. doi: 10.1111/aor.12247. Epub 2014 Jan 7.
6
The Neutrophil-Lymphocyte Ratio and Survival During Left Ventricular Assist Device Support.中性粒细胞与淋巴细胞比值与左心室辅助装置支持期间的生存率。
J Card Fail. 2019 Mar;25(3):188-194. doi: 10.1016/j.cardfail.2019.01.005. Epub 2019 Jan 15.
7
Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).西雅图心力衰竭模型和HeartMate II风险评分在非依赖血管活性药物的晚期心力衰竭患者中的准确性:ROADMAP研究(门诊心力衰竭患者左心室辅助装置与药物治疗的风险评估及比较效果)的见解
Circ Heart Fail. 2017 May;10(5). doi: 10.1161/CIRCHEARTFAILURE.116.003745.
8
Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results.采用左心室辅助装置的心肌恢复前瞻性多中心研究(RESTAGE-HF[心力衰竭 D 期缓解]):中期和主要终点结果。
Circulation. 2020 Nov 24;142(21):2016-2028. doi: 10.1161/CIRCULATIONAHA.120.046415. Epub 2020 Oct 26.
9
Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.半乳糖凝集素-3在晚期心力衰竭患者中、左心室辅助装置支持期间及心脏移植后的动态变化及预后作用
BMC Cardiovasc Disord. 2016 Jun 14;16:138. doi: 10.1186/s12872-016-0298-z.
10
Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury.左心室辅助装置支持对心血管应激、纤维化、液体平衡、炎症和肾损伤的生物标志物的影响。
JACC Heart Fail. 2015 Jan;3(1):30-39. doi: 10.1016/j.jchf.2014.06.013. Epub 2014 Nov 12.

引用本文的文献

1
Advances in neutrophil extracellular traps and ferroptosis in sepsis-induced cardiomyopathy.脓毒症诱导的心肌病中中性粒细胞胞外陷阱与铁死亡的研究进展
Front Immunol. 2025 Apr 28;16:1590313. doi: 10.3389/fimmu.2025.1590313. eCollection 2025.

本文引用的文献

1
Advances in crosstalk among innate immune pathways activated by mitochondrial DNA.线粒体DNA激活的固有免疫途径间串扰的研究进展
Heliyon. 2024 Jan 3;10(1):e24029. doi: 10.1016/j.heliyon.2024.e24029. eCollection 2024 Jan 15.
2
The Impact of Positive Inotropic Therapy on Hemodynamics and Organ Function in Acute Heart Failure: A Differentiated View.正性肌力治疗对急性心力衰竭血流动力学和器官功能的影响:一种差异化观点
J Pers Med. 2023 Dec 22;14(1):17. doi: 10.3390/jpm14010017.
3
Role of Genetic Polymorphisms in the Development of Complications in Patients with Implanted Left Ventricular Assist Devices: HeartWare, HeartMate II, and HeartMate 3.
基因多态性在植入左心室辅助装置患者并发症发生中的作用:HeartWare、HeartMate II和HeartMate 3
J Clin Med. 2023 Nov 22;12(23):7235. doi: 10.3390/jcm12237235.
4
The Society of Thoracic Surgeons Intermacs 2023 Annual Report: Focus on Magnetically Levitated Devices.胸外科医师学会 Intermacs 2023 年度报告:重点关注磁悬浮设备。
Ann Thorac Surg. 2024 Jan;117(1):33-44. doi: 10.1016/j.athoracsur.2023.11.004. Epub 2023 Nov 8.
5
Exploring key genes associated with neutrophil function and neutrophil extracellular traps in heart failure: a comprehensive analysis of single-cell and bulk sequencing data.探索与心力衰竭中中性粒细胞功能和中性粒细胞胞外诱捕网相关的关键基因:单细胞和批量测序数据的综合分析
Front Cell Dev Biol. 2023 Oct 24;11:1258959. doi: 10.3389/fcell.2023.1258959. eCollection 2023.
6
Anticoagulants in adult extracorporeal membrane oxygenation: alternatives to standardized anticoagulation with unfractionated heparin.成人体外膜肺氧合中的抗凝剂:替代标准化抗凝治疗的普通肝素。
Eur J Clin Pharmacol. 2023 Dec;79(12):1583-1594. doi: 10.1007/s00228-023-03568-3. Epub 2023 Sep 23.
7
Dual antiplatelet therapy inhibits neutrophil extracellular traps to reduce liver micrometastases of intrahepatic cholangiocarcinoma.双联抗血小板治疗抑制中性粒细胞胞外诱捕网以减少肝内胆管细胞癌的肝微转移。
Cancer Lett. 2023 Jul 28;567:216260. doi: 10.1016/j.canlet.2023.216260. Epub 2023 Jun 7.
8
Neutrophil extracellular traps in acute coronary syndrome.急性冠状动脉综合征中的中性粒细胞胞外陷阱
J Inflamm (Lond). 2023 May 10;20(1):17. doi: 10.1186/s12950-023-00344-z.
9
Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure.心力衰竭患者内皮功能障碍的分子机制及治疗意义。
Int J Mol Sci. 2023 Feb 21;24(5):4321. doi: 10.3390/ijms24054321.
10
HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support.HFSA 专家共识声明:关于永久性机械循环支持患者的医疗管理。
J Card Fail. 2023 Apr;29(4):479-502. doi: 10.1016/j.cardfail.2023.01.009. Epub 2023 Feb 22.